ArticleOncology letters2026

Extended cycles of anti-GD2 antibody dinutuximab beta treatment combined with chemotherapy in patients with relapsed or refractory neuroblastoma: A retrospective study.

Zhiqi Gong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.